Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

Daan van den Broek*, T. Jeroen N. Hiltermann, Bonne Biesma, Winand N. M. Dinjens, Nils A. 't Hart, John W. J. Hinrichs, Mathie P. G. Leers, Kim Monkhorst, Matthijs van Oosterhout, Volkher Scharnhorst, Ed Schuuring, Ernst-Jan M. Speel, Michel M. van den Heuvel, Ron H. N. van Schaik, Jan von der Thusen, Stefan M. Willems, Leonie de Visser, Marjolijn J. L. Ligtenberg

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number1521
Number of pages7
JournalFrontiers in Oncology
Volume9
DOIs
Publication statusPublished - 22 Jan 2020

Keywords

  • predictive tumor markers
  • carcinoma
  • non-small cell lung
  • molecular targeted therapy
  • molecular pathology
  • precision medicine
  • CIRCULATING TUMOR DNA
  • OF-AMERICAN-PATHOLOGISTS
  • SYSTEMIC TREATMENT
  • EXPERT OPINION
  • DIAGNOSTICS
  • QUALITY
  • PD-L1
  • NSCLC
  • RECOMMENDATIONS
  • ONCOLOGY

Cite this